Clinical research trials are key to developing new ways to prevent, detect, and treat cancer. It is through clinical trials that doctors can determine whether new treatments are safe and effective and work better than current treatments. When you take part in a clinical trial, you add to the body of knowledge about cancer, which will hopefully lead to new and improved treatments.
All clinical research trials must conform to strict international and/or local rules, guidelines and laws. These rules help protect the rights and safety of those who volunteer to take part.
Before agreeing to participate, participants will learn about possible risks and benefits of the therapy being studied. Participants may withdraw from the research trial at any time.
Before any clinical research trial begins, it must be approved by an Ethics Committee (EC) and/or an Institutional Review Board (IRB), which include people with medical and non-medical backgrounds. These groups consider whether proposed clinical research trials are safe and well planned. They also review trials to ensure that participants are adequately informed about the risks of participating in clinical research. In all clinical research trials, the health of each participant is closely monitored during the course of the trial.
For more information on TESARO clinical trials, please visit Our Clinical Trials.
For additional information on clinical trials, visit http://www.cancer.gov/about-nci/organization/clinical-center-fact-sheet